Related Experiment Video

Updated: Jun 2, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Therapeutic potential of anticancer immunotoxins

Swati Choudhary1, Mrudula Mathew, Rama S Verma

  • 1Stem Cell and Molecular Biology Laboratory, Department of Biotechnology, Indian Institute of Technology Madras, Chennai, TN, India.

Drug Discovery Today
|April 23, 2011
PubMed

Insights

Immunotoxins are engineered proteins targeting cancer cells for cell death. This review highlights clinical findings of various chimeric toxins, including the FDA-approved denileukin diftitox.

Area of Science:

  • Biotechnology
  • Oncology
  • Immunology

Background:

  • Immunotoxins are engineered proteins combining tumor-targeting ligands with cytotoxic payloads.
  • They leverage cell surface receptor binding and endocytosis for targeted cell killing.
  • Advances in protein engineering and phage display enhance targeting moiety selection.

Purpose of the Study:

  • To review key clinical findings of various chimeric toxins.
  • To discuss the development and application of immunotoxins in cancer therapy.

Main Methods:

  • Literature review of clinical studies on immunotoxins.
  • Analysis of data from trials involving denileukin diftitox and other agents like BL22.

Main Results:

  • Denileukin diftitox is the sole FDA-approved immunotoxin.
  • Other immunotoxins, such as BL22, are in various stages of clinical development.
  • Clinical studies demonstrate the potential of immunotoxins in cancer treatment.

Conclusions:

  • Immunotoxins represent a promising therapeutic strategy in oncology.
  • Continued research and development are crucial for expanding their clinical utility.
  • Targeted delivery of toxins offers a precise approach to cancer cell elimination.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...